Analyst Ratings for Regeneron Pharma (REGN) [Sells]
REGN Rating Summary
REGN Price Target Summary
- Highest: $1,189.00 (RBC Capital)
- Lowest: $720.00 (BofA Securities)
- Average: $1,029.05
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$1,029.05 (+13.5%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 72%
Avg. $ Target:
$1,029.05 (+13.5%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 72%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/5/2022 | BofA Securities » Updated 4/12/2024 |
Geoff Meacham | Downgrade | Underperform (Neutral) |
720.00 (710.00) |
616.82 (906.54) |
46.97% | Details |
